Pourhassan Nader 4

Accession 0001807094-20-000005

CIK 0001175680other

View on SEC.gov Company Profile

Filed

May 3, 8:00 PM ET

Accepted

May 4, 9:55 PM ET

Size

55.8 KB

Accession

0001807094-20-000005

Insider Transaction Report

Form 4

Period: 2020-04-30

CytoDyn Inc.CYDY

Pourhassan Nader

Chief Operating Officer

Transactions

Exercise/Conversion
Common Stock
2020-04-30$0.75/sh+152,000$114,000→ 994,417 total
Exercise/Conversion
Common Stock
2020-04-30$0.80/sh+600,000$480,000→ 2,394,217 total
Exercise/Conversion
Common Stock
2020-04-30$0.87/sh+325,000$282,750→ 842,417 total
Exercise/Conversion
Common Stock
2020-04-30$0.39/sh+187,817$73,249→ 3,698,584 total
Sale
Common Stock
2020-05-01$3.26/sh−1,399,685$4,569,132→ 2,079,062 total
Exercise/Conversion
Employee Stock Option
2020-04-30+325,000→ 0 total
Exercise: $0.87From: 2015-11-23Exp: 2025-11-23→ Common Stock (325,000 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+600,000→ 0 total
Exercise: $1.09From: 2019-06-01Exp: 2026-06-01→ Common Stock (600,000 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+50,000→ 0 total
Exercise: $0.90From: 2019-06-18Exp: 2029-06-18→ Common Stock (50,000 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+116,550→ 233,450 total
Exercise: $0.49From: 2019-06-08Exp: 2028-06-08→ Common Stock (116,550 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+150,000→ 0 total
Exercise: $0.90From: 2018-06-30Exp: 2025-06-30→ Common Stock (150,000 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+600,000→ 0 total
Exercise: $0.80From: 2018-02-15Exp: 2023-02-15→ Common Stock (600,000 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+2,000,000→ 0 total
Exercise: $0.63From: 2019-12-19Exp: 2029-12-19→ Common Stock (2,000,000 underlying)
Exercise/Conversion
Common Stock
2020-04-30$0.90/sh+200,000$180,000→ 517,417 total
Exercise/Conversion
Common Stock
2020-04-30$1.09/sh+600,000$654,000→ 1,594,417 total
Sale
Common Stock
2020-05-04$2.79/sh−1,201,652$3,353,090→ 908,343 total
Exercise/Conversion
Employee Stock Option
2020-04-30+1,000,000→ 0 total
Exercise: $0.56From: 2019-04-08Exp: 2028-11-08→ Common Stock (1,000,000 underlying)
Exercise/Conversion
Employee Stock Option
2020-05-04+30,933→ 156,250 total
Exercise: $0.39From: 2019-10-07Exp: 2029-10-07→ Common Stock (30,933 underlying)
Exercise/Conversion
Common Stock
2020-04-30$0.57/sh+199,800$113,886→ 1,794,217 total
Exercise/Conversion
Common Stock
2020-04-30$0.56/sh+1,000,000$565,000→ 3,510,767 total
Exercise/Conversion
Common Stock
2020-04-30$0.63/sh+2,000,000$1,260,000→ 5,698,584 total
Exercise/Conversion
Common Stock
2020-04-30$0.49/sh+116,550$57,110→ 2,510,767 total
Sale
Common Stock
2020-04-30$3.53/sh−2,219,837$7,838,688→ 3,478,747 total
Exercise/Conversion
Common Stock
2020-05-04$0.39/sh+30,933$12,064→ 2,109,995 total
Exercise/Conversion
Employee Stock Option
2020-04-30+152,000→ 0 total
Exercise: $0.75From: 2016-01-04Exp: 2026-01-04→ Common Stock (152,000 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+199,800→ 100,200 total
Exercise: $0.57From: 2019-06-01Exp: 2027-06-01→ Common Stock (199,800 underlying)
Exercise/Conversion
Employee Stock Option
2020-04-30+187,817→ 187,183 total
Exercise: $0.39From: 2019-04-07Exp: 2029-10-07→ Common Stock (187,817 underlying)

Holdings

Common Stock
(indirect: By Spouse)
15,570

Footnotes (6)

[F1]This transaction was executed in multiple trades at prices ranging from $3.44 to $3.74. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]This transaction was executed in multiple trades at prices ranging from $3.13 to $3.54. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]This transaction was executed in multiple trades at prices ranging from $2.53 to $3.00. The price above reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]Option grant vests over a three year period beginning June 1, 2018.
[F5]Option grant vests over a three year period beginning June 8, 2019.
[F6]Option grant vests in equal monthly installments over a 12-month period beginning October 7, 2019.

Documents

2 files

Issuer

CytoDyn Inc.

CIK 0001175680

→

Entity typeother

Related Parties

filerCIK 0001532878

Filing Metadata

Form type: 4
Filed: May 3, 8:00 PM ET
Accepted: May 4, 9:55 PM ET
Size: 55.8 KB

View on SEC.gov